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Influenza virus, belongs to the family Orthomyxoviridae and genus Influenza virus A, 
causes major disease problems and serious economical losses in poultry industry. Highly 
pathogenic avian influenza H5N1 subtype which is associated with acute infection with 
high morbidity and mortality in susceptible birds, is still enzootic in poultry in Asia as 
well as European and African countries. The virus may also possess serious threat to the 
emergence of influenza pandemic in humans. Vaccination is one of the biosafety 
measures which has the greatest impact on improving global health and preventing 
morbidity and mortality due to avian influenza (AI) infection. The explosion of 
knowledge in molecular immunology has paved radical developments in vaccine 
technology. Immunization with DNA vaccines and genetic adjuvants as 
immunostimulators is an attractive approach in the development of future generations of 
vaccines and adjuvants.    The viral envelope proteins, hemagglutinin (HA or H) and 
neuraminidase (NA or N), have been shown to play key roles in triggering protective 
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immune responses against AI infection. Meanwhile, nucleocapsid protein (NP) may play 
a central role in cross protection between AI virus serotypes.  The Mycobacterium 
tuberculosis Early Secreted Antigenic Target-6 (ESAT-6) antigen has been shown to 
elicit both humoral and cellular immunity, thus it has an ability to act as a genetic 
adjuvant. This study examined the ability of ESAT-6 to modulate antibody response 
against H5 following vaccination with DNA vaccine in chickens. In order to study the 
immunological properties of AIV DNA vaccines, several recombinant plasmids 
pcDNA3.1/H5, pcDNA3.1/N1, pcDNA3.1/NP, pcDNA3.1/H5-ESAT6, pcDNA3.1/N1-
ESAT6 and pcDNA3.1/NP-ESAT6 were constructed. The recombinant plasmid 
constructs were confirmed by restriction enzymes and sequence analyses. The expression 
of genes of interest in cell culture was confirmed by immunofluorescence test and 
Western blot analysis. The immunogenicity of the DNA vaccine pcDNA3.1./H5 with 
and without the presence of ESAT-6 in specific-pathogen-free (SPF) chicks was 
determined. Sera obtained from the chickens immunized with pcDNA3.1/H5 and 
pcDNA3.1/H5-ESAT6 demonstrated viral neutralizing activities based on 
haemagglutination inhibition (HI) test. The sera collected from chicks immunized with 
pcDNA3.1/H5-ESAT6 have higher HI titer compared to the group which was 
immunized with pcDNA3.1/H5. However, the increase in HI titer at different post 
immunization days between these groups was not statistically significant. When the 
tissue samples from the chest muscle of injection site and spleen from chickens 
immunized with the DNA vaccine were analyzed by reverse transcriptase polymerase 
chain reaction (RT-PCR), all the samples were positive for H5 specific transcripts. In 
summary, the current study delineated that the constructed recombinant plasmids were 
iii 
 
transcriptionally active in the in vivo chicken model and DNA immunization in SPF 
chicks with pcDNA3.1/H5 and pcDNA3.1/H5-ESAT6 produced humoral immune 
response. In conclusion, future studies are required to explore the role of ESAT-6 gene 
of Mycobacterium tuberculosis as an effective genetic adjuvant for H5 DNA vaccine in 
chickens. 
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Virus selesema tergolong dalam famili Orthomyxoviridae dan genus Influenza virus A, 
adalah penyebab masalah penyakit major dan juga kerugian serius dalam industri ayam.  
Selesema burung yang amat patogenik subtip H5N1 yang menyebabkan jangkit akut 
dengan kadar jangkitan dan kematian yang tinggi bagi burung boleh dijangkiti, masih 
enzotik dalam ayam di Asia  begitu juga di Eropah dan Afrika. Virus ini mempunyai 
ancaman yang besar dalam penjelmaan pandemik selesema dalam manusia. Vaksinasi 
adalah salah satu langkah biosekuriti yang mempunyai impak yang ketara dalam 
meningkatkan tahap kesihatan global dan pencegahan jangkitan dan kematian yang 
berkaitan dengan selesema burung (AI). Perkembangan dalam pengetahuan imunologi 
molekul telah mengorak pembangunan radikal dalam teknologi vaksin. Imunisasi 
menggunakan vaksin DNA dan adjuvan genetik sebagai perangsang keimunan 
merupakan satu pendekatan yang menarik dalam pembangunan ke depan generasi vaksin 
dan adjuvan.  
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Protein envelop virus, Hemagglutinin (HA atau H) dan neuraminidase (NA atau N) telah 
memainkan peranan utama dalam mencetus gerak balas imun pelindung terhadap 
jangkitan AI. Sementara itu, protein nukleokapsid (NP) memainkan peranan sentral  
dalam perlindungan silang antara serotip virus AI. Antigen ESAT-6 Mikrobakterium 
tuberkulosis berupaya merangsang keimunan humor dan sel seterusnya berkebolehan 
bertindak sebagai adjuvan genetik. Kajian ini menerangkan kebolehan ESAT-6 untuk 
mengawal gerak balas antibodi terhadap H5 selepas vaksinasi dengan vaksin DNA dalam 
ayam. Bagi mengkaji ciri keimunan vaksin DNA AIV, plasmid rekombinan berikut telah 
dihasilkan, pcDNA3.1/H5, pcDNA3.1/N1, pcDNA3.1/NP, pcDNA3.1/H5-ESAT6, 
pcDNA3.1/N1-ESAT6 dan pcDNA3.1/NP-ESAT6. Pembinaan plasmid rekombinan 
disahkan dengan penghadaman oleh enzim pembatas dan analisis jujukan. Ekspresi gen 
pilihan dalam kultur sel telah disahkan dengan ujian antibodi imunopendarfluoran dan 
analisis penompokan Western. Tahap keimunan vaksin DNA pcDNA3.1./H5 sama ada 
dengan kehadiran ESAT-6 atau tidak dalam ayam bebas-patogen-spesifik adalah 
ditentukan. Serum yang diperoleh daripada ayam yang telah disuntik dengan 
pcDNA3.1/H5 dan pcDNA3.1/H5 telah menghasilkan aktiviti peneutralan virus 
menerusi ujian perencatan hemagglutinin (HI). Sera yang dikumpulkan dari ayam yang 
disuntik dengan  pcDNA3.1/H5-ESAT6 menunjukkan dengan jelas titer HI yang tinggi 
dibandingkan dengan kumpulan yang disuntik dengan pcDNA3.1/H5. Namun, 
peningkatan pada titer HI tersebut adalah tidak signifikan secara statistik. Apabila 
sampel tisu daripada tapak suntikan pada otot dada dan limpa daripada ayam yang telah 
diimunkan dengan vaksin DNA dianalisis menggunakan tindak balas rantai polimerase 
transkriptase membalik  (RT-PCR), kesemua sampel adalah positif bagi transkrip 
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spesifik H5. Sebagai rumusan, kajian ini menerangkan bahawa plasmid rekombinan yang 
dibina adalah aktif dalam menghasilkan transkrip secara in vivo dalam model ayam dan 
pengimunan ayam SPF  dengan pcDNA3.1/H5 dan pcDNA3.1/H5-ESAT6 telah 
menunjukkan penghasilan tindak balas antibodi. Kesimpulannya, kajian lanjut perlu 
dilaksanakan bagi mengkaji peranan gen ESAT-6 Mikrobakterium tuberkulosis sebagai 
adjuvan genetik yang efektif bagi vaksin DNA H5 dalam ayam. 
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 CHAPTER 1 
 
INTRODUCTION 
 
1.1  Overview 
 
Influenza is a highly contagious and re-emerging disease that has burdened humans and 
animals since ancient times. According to the influenza virus inherent ability to infect a 
broad range of animal hosts and also their vast avian reservoirs, influenza continues to 
represent one of the most serious health and economic threats to humans’ worldwide 
(Dubovi et al, 2004; Webster et al, 1992). Avian influenza is widely monitored in 
domestic poultry including chickens, turkeys, quails, domestic ducks, ratites and 
commercially-raised birds (WHO, 2008). The disease can result in severe economic loss 
if not detected immediately. If detected, depopulation of the affected and exposed flock 
and neighboring farms is carried out to contain the virus and prevent the spread of the 
disease. Depopulating or culling is the most economical and straightforward method of 
controlling the virus but this kind of measure is not possible in a wildlife setting (review 
in ECLAC, 2005-2006). For this reason, prevention and control of avian influenza in 
poultry industry are the two most critical biosafety measures in combination with 
surveillance. Influenza A viruses infecting poultry flocks are divided into two groups 
based on their apparent pathogenicity: high pathogenic avian influenza (HPAI) and low 
pathogenic avian influenza (LPAI). HPAI viruses are composed of H5 and H7 
hemagglutinin subtypes and may result in flock mortality as high as 100%. LPAI viruses 
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belong to any hemagglutinin subtype and usually present as a much milder respiratory 
disease, causing depression and decrease in egg production, but in conjunction with 
secondary viral and/or bacterial infections or poor environmental conditions can cause 
severe disease with high mortality (Kahn 2005, Lee and Suarez, 2005).  
 
In Peninsular Malaysia, the poultry industry has developed to a most scientifically 
advanced industry and contributes to more than 60% of the total value of livestock. In 
order to maintain and increase the productivity of poultry products, both vaccination and 
therapeutic or prophylactic use of drugs play an important role in animal disease control. 
Several LPAI viruses of the H4N3, H4N6, H3N6 and H9N2 subtypes in domestic duck 
(Jasbir et al., 1999; Aini and Ibrahim 1986) and in passerine birds (Ibrahim et al., 1990) 
have been reported in Malaysia. Recently, a LPAI virus, subtype H5N2, was identified in 
ducks exported from a farm in Perak State, Malaysia to Singapore (FAO, 2004). The first 
case of the HPAI virus, subtype H5N1 was reported in two free-range chickens in a flock 
of approximately 60 birds located in the state of Kelantan, Malaysia near the Thailand 
border, in 19 August 2004 (OIE Country Report). A fresh case of H5N1 was reported in 
a flock of free range poultry in 19 February 2006 and the most recent case of H5N1 in 
village chickens in January of 2007 (WHO, 2008). This frequent occurrence of AI 
infection in recent years has made vaccination a necessity. 
 
Currently two types of vaccines are in use:  killed and live virus vaccines. The killed 
vaccines can be divided into whole virus vaccines which were the first to be developed 
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